Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-25T20:35:01.940Z Has data issue: false hasContentIssue false
  • English
  • Français

A comparison of intubation conditions and time-course of action with rocuronium and mivacurium for day case anaesthesia

Published online by Cambridge University Press:  01 June 2007

P. E. Pendeville ,
F. Lois  and
J.-L. Scholtes
P. E. Pendeville*
Affiliation:
Cliniques Universitaires Saint-Luc, UCL Medical School, Department of Anaesthesiology, Brussels, Belgium
F. Lois
Affiliation:
Cliniques Universitaires Saint-Luc, UCL Medical School, Department of Anaesthesiology, Brussels, Belgium
J.-L. Scholtes
Affiliation:
Cliniques Universitaires Saint-Luc, UCL Medical School, Department of Anaesthesiology, Brussels, Belgium
*
Correspondence to: Philippe Pendeville, Department of Anaesthesiology, Saint-Luc University Hospital, Avenue Hippocrate 10/1821, 1200 Brussels, Belgium. E-mail: [email protected]; Tel: +32 2764 1821; Fax: +32 2764 3699
Get access

Summary

Background and objective

To compare intubation conditions and time-course of action of rocuronium and mivacurium for day case anaesthesia.

Methods

Fifty ASA I or II patients were enrolled. Anaesthesia was induced with propofol using a target controlled infusion system (target 6–8 μg mL−1) and sufentanil (0.25 μg kg−1). It was maintained with propofol (target 3.5–4.5 μg mL−1) and 50% nitrous oxide in oxygen. Muscle relaxation was achieved with either mivacurium (0.15 mg kg−1) or rocuronium (0.3 mg kg−1). Neuromuscular transmission was monitored and recorded continuously by acceleromyography using a TOF-WATCH SX (Biometer™/; Denmark) with supramaximal train-of-four stimulation of the ulnar nerve. Tracheal intubation was carried out by an experienced anaesthetist blinded to the type of the muscle relaxant. Intubation conditions were evaluated according to a standard scheme (ease of laryngoscopy, position of vocal cords, airway reaction and limb movements).

Results

Intubation conditions were good or excellent for both mivacurium 0.15 mg kg−1 (good = 8%; excellent = 92%) and rocuronium 0.3 mg kg−1 (excellent = 100%). Times to maximum blockade and clinical duration were not different.

Conclusions

There is no significant difference between mivacurium and rocuronium concerning the onset and the recovery of muscle relaxation. Rocuronium is an alternative to mivacurium for short procedures, without the risk of unexpected prolonged relaxation due to a possible defect in plasma cholinesterase.

Keywords

ANAESTHESIA GENERALAMBULATORY SURGERYNEUROMUSCULAR BLOCKING AGENTS, mivacurium, rocuronium
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 24 , Issue 6 , June 2007 , pp. 546 - 550
Copyright
Copyright © European Society of Anaesthesiology 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Savarese, JJ, Kitz, RJ. The quest for a short-acting non-depolarising neuromuscular blocking agent. Acta Anaesthesiol Scand 1973; 53: 43–58.Google Scholar
2.Pollard, BJ, Chetty, MS, Wilson, A, Healy, TEJ. Intubating conditions and time-course of action of low-dose rocuronium bromide in day-case dental surgery. Europ J Anaesthesiol 1995; 12 (11): 81–83.Google Scholar
3.Scheller, MS, Zornow, MH, Saidman, LJ. Tracheal intubation without the use of muscle relaxants: a technique using propofol and varying doses of alfentanil. Anesth Analg 1992; 75: 788–793.CrossRefGoogle ScholarPubMed
4.Savarese, JJ, Ali, HH, Basta, SJ et al. . The clinical neuromuscular pharmacology of mivacurium bromide (BW1090U). Anesthesiology 1988; 68: 723–732.CrossRefGoogle Scholar
5.Pino, RM, Ali, HH, Denman, WT, Barrett, PS, Schwarz, A. A comparison of the intubation conditions between mivacurium and rocuronium during balanced anesthesia. Anesthesiology 1998; 88: 673–678.CrossRefGoogle ScholarPubMed
6.Prien, Th, Zahn, P, Menges, M, Brüssel, Th. 1xD90 dose of rocuronium bromide: tracheal intubation conditions and time-course of action. Eur J Anaesthesiol 1995; 12: 85–90.Google Scholar
7.Pühringer, FK, Khuenl-Brady, KS, Koller, J, Mitterschiffhaler, G. Evaluation of the endotracheal intubating conditions of rocuronium and succinylcholine in outpatient surgery. Anesth Analg 1992; 75: 37–40.Google ScholarPubMed
8.Tang, J, Joshi, GP, White, PF. Comparison of rocuronium and mivacurium to succinylcholine during outpatient laparoscopic surgery. Anesth Analg 1996; 82: 994–998.Google ScholarPubMed
9.Mellinghoff, H, Diefenbach, C, Bischoff, A, Grond, S, Buzello, W. Dose-response relationship of rocuronium bromide during intravenous anaesthesia. Eur J Anaesthesiol 1994; 11 (Suppl 9): 20–24.Google Scholar
10.Meistelman, C, Plaude, B, Donati, F. Rocuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans. Can J Anesthesia 1992; 39: 665–669.CrossRefGoogle ScholarPubMed
11.Wierda, JMKH. Rocuronium for muscle relaxation in ambulatory patients. In: Crul, JF, ed. Clinical Aspects of Rocuronium Bromide. Turnhout, Belgium: Interface, 1996: 19–27.Google Scholar
12.Barclay, K, Eggers, K, Asai, T. Low-dose rocuronium improves conditions for tracheal intubation after induction or anaesthesia with propofol and alfentanil. Br J Anaesth 1997; 78 (1): 92–94.CrossRefGoogle ScholarPubMed
13.Robertson, EN, Driessen, JJ, Vogt, M, De Boer, H, Scheffer, J. Pharmacodynamics of rocuronium 0.3 mg kg−1 in adult patients with and without renal failure. Eur J Anaesthesiol 2005; 22: 929–932.CrossRefGoogle ScholarPubMed
14.Booij, LHD, Knape, HTA. The neuromuscular blocking effect of Org 9426. A new intermediately-acting steroidal non depolarising muscle relaxant in man. Anaesthesia 1991; 46: 341–343.CrossRefGoogle ScholarPubMed
15.Levy, JH, Davis, GK, Duggan, J, Szlam, F. Determination of hemodynamics and histamine release of rocuronium when administered in increased doses under N2O/O2–sufentanil anesthesia. Anesth Analg 1994; 78: 318–321.CrossRefGoogle ScholarPubMed
16.Ostergaard, D, Jensen, E, Jensen, FS et al. . The duration of action of mivacurium induced block in patients homozygous for the atypical plasma cholinesterase gene. Anesthesiology 1991; 75: A774.CrossRefGoogle Scholar
17.Goudsouzian, NG, D’Hollander, AA, Viby-Mogensen, J. Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency. Anesth Analg 1993; 77 (1): 183–185.CrossRefGoogle ScholarPubMed
18.Cook, DR, Freeman, JA, Lai, AA et al. . Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. Br J Anaesth 1992; 69 (6): 580–585.CrossRefGoogle ScholarPubMed
19.Khuenl-Brady, KS, Pomaroli, A, Pühringer, F et al. . The use of rocuronium in patients with chronic renal failure. Anaesthesia 1993; 48: 873–875.CrossRefGoogle ScholarPubMed
20.Cooper, RA, Maddineni, VR, Mirakhur, RK et al. . Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide during isoflurane anaesthesia in patients with and without renal failure. Br J Anaesth 1993; 71: 222–226.CrossRefGoogle ScholarPubMed
21.Robertson, EN, Driesen, JJ, Vogt, M, De Boer, H, Scheffer, GJ. Pharmacodynamics of rocuronium 0.3 mg kg−1 in adult patients with and without renal failure. Eur J Anaesthesiol 2005; 22: 929–932.CrossRefGoogle ScholarPubMed
22.Khalil, M, D’Honneur, G, Duvaldestin, P et al. . Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis. Anesthesiology 1994; 80: 1241–1247.CrossRefGoogle ScholarPubMed
23.Magorian, T, Wood, P, Caldwell, J et al. . The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease. Anesth Analg 1995; 80: 754–759.Google ScholarPubMed
24.Mertes, PM, Laxenaire, MC, Alla, F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999–2000. Anesthesiology 2003; 99: 536–545.CrossRefGoogle ScholarPubMed
25.Laxenaire, MC, Mertes, PM. Anaphylaxis during anaesthesia: results of a two-year survey in France. Br J Anaesth 2001; 87: 549–558.CrossRefGoogle ScholarPubMed
26.Guttormsen, AB. Allergic reactions during anaesthesia: increased attention to the problem in Denmark and Norway. Acta Anaesthesiol Scand 2001; 45: 1189–1190.CrossRefGoogle Scholar
27.Garvey, LH, Roed-Petersen, J, Menne, T, Husum, B. Danish Anaesthesia Allergy Centre: preliminary results. Acta Anaesthesiol Scand 2001; 45: 1204–1209.CrossRefGoogle ScholarPubMed
28.Bhananker, SM, O’Donnell, JT, Salemi, JR, Bishop, MJ. The risk of anaphylactic reactions to rocuronium in the United States is comparable to that of vecuronium: an analysis of Food and Drug Administration reporting of adverse events. Anesth Analg 2005; 101: 819–822.CrossRefGoogle ScholarPubMed